Press Releases and News
We sat down over a virtual cup of coffee to interview Sandeep Kondaveeti, Research and Development Scientist at Teva Pharmaceuticals. His research expertise is in synthesis and characterization of inorganic / organic compounds, nano-materials, and protein complexes. Editor:I understand you currently work in the area of biological drug product development and formulation; can you tell … “An Interview with Sandeep Kondaveeti, Research and Development Scientist at Teva Pharmaceuticals”
Orders for the company’s AQS3pro platform grew over 500% in the second full year since product
launch, and the company closed a $6.4 million Series D Preferred Stock extension to support
continued aggressive growth in 2021.
We sat down over a virtual cup of coffee to interview Dr. Shawn Owen, Assistant Professor of Pharmaceutical Chemistry at the University of Utah. Owen is an experienced pharmaceutical scientist with a demonstrated history of success in the higher education industry. Skilled in antibody engineering and bio-conjugation chemistry applied to developing therapeutic and diagnostic platforms. … “An Interview with Shawn Owen, Assistant Professor of Pharmaceutical Chemistry at the University of Utah”
We sat down in December 2020 over a virtual cup of coffee to interview Chris Roberts, Professor of Chemical and Biomolecular Engineering at the University of Delaware (UD). He received a Bachelors of Chemical Engineering degree from UD, and a Ph.D. in Chemical Engineering from Princeton University. His research includes experimental and theoretical fundamentals and … “An Interview with Chris Roberts, Professor of Chemical and Biomolecular Engineering at the University of Delaware (UD)”
We sat down over a virtual cup of coffee in November 2020 to interview Patrick Ahl, Assistant Principal Scientist, Merck. Patrick’s current research at Merck focuses on fostering innovation to accelerate and improve vaccine formulation development. Innovation efforts include liquid handling robotics, differential scanning fluorometry, dynamic light scattering, automated western gel electrophoresis, and FTIR spectroscopy. … “An Interview with Patrick Ahl, Assistant Principal Scientist, Merck”
We sat down over a virtual cup of coffee in October 2020 to interview Chief Commercial Officer of RedShiftBio: Jeff Zonderman. Editor: Can you tell us a bit about your background? What was your journey to working at RSB? Jeff Zonderman: I am very lucky to have worked for some great technology companies during very … “An Interview with Jeff Zonderman”
RedShiftBio, a provider of innovative analytical solutions for protein characterization used in biotherapeutic drug development, appoints Nigel Danielson-Ewing as Director of Product Management.
A new collaborative study from RedshiftBio (Burlington, MA) and a Major Pharmaceutical Company published in the Journal of Pharmaceutical Sciences provides compelling evidence of the benefits of the award winning AQS3pro, a Microfluidic Modulation Spectroscopy platform from RedShift BioAnalytics, Inc., for the biopharmaceutical industry.
We sat down over a virtual cup of coffee in September 2020 to interview Dr. John Carpenter, Professor in the Department of Pharmaceutical Sciences in the Skaggs School of Pharmacy at the University of Colorado Anschutz Medical Campus. His research interests include mechanisms for protein degradation and stabilization in pharmaceutical formulations, during bioprocessing and in … “An Interview with Dr. John Carpenter”
RedShiftBio announced its award winning AQS3pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in India.